Metabolite and thymocyte development defects in ADA-SCID mice receiving enzyme replacement therapy
Abstract Deficiency of adenosine deaminase (ADA, EC3.5.4.4), a housekeeping enzyme intrinsic to the purine salvage pathway, leads to severe combined immunodeficiency (SCID) both in humans and mice. Lack of ADA results in the intracellular accumulation of toxic metabolites which have effects on T cel...
Saved in:
Main Authors: | Federico A. Moretti, Giuliana Giardino, Teresa C. H. Attenborough, Athina Soragia Gkazi, Ben K. Margetts, Giancarlo la Marca, Lynette Fairbanks, Tessa Crompton, H. Bobby Gaspar |
---|---|
Format: | article |
Language: | EN |
Published: |
Nature Portfolio
2021
|
Subjects: | |
Online Access: | https://doaj.org/article/f65c7cd9d5074750a94e03ee0d0444ee |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Pegademase bovine (PEG-ADA) for the treatment of infants and children with severe combined immunodeficiency (SCID
by: Claire Booth, et al.
Published: (2009) - Ada user journal
-
News from ADA congress 2007
by: Editorial team Diabetes Mellitus
Published: (2007) -
Reevaluation of NOD/SCID Mice as NK Cell-Deficient Models
by: Miao Miao, et al.
Published: (2021) -
Biografías: Charles Babbage, Augusta Ada Byron
by: José Beltrán, et al.
Published: (2012)